A Systematic Review of Economic Evaluations Conducted for Interventions to Screen, Treat, and Manage Retinopathy of Prematurity (ROP) in the United States, United Kingdom, and Canada

References

• Terry TL. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. report of cases-clinical aspects. Trans Am Ophthalmol Soc. 1942;40:262–284.
   PubMedGoogle Scholar
• An international classification of retinopathy of prematurity. The committee for the classification of retinopathy of prematurity. Arch Ophthalmol. 1984 Aug;102(8):1130–1134. doi:10.1001/archopht.1984.01040030908011.
   PubMed Web of Science ®Google Scholar
• International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999. doi:10.1001/archopht.123.7.991.
   PubMed Web of Science ®Google Scholar
• Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008 Feb;84(2):77–82. doi:10.1016/j.earlhumdev.2007.11.009.
   PubMed Web of Science ®Google Scholar
• Hariharan L, Gilbert CE, Quinn GE, et al. Reducing Blindness from Retinopathy of Prematurity (ROP) in argentina through collaboration, advocacy and policy implementation. Health Policy Plan. 2018 Jun 1;33(5):654–665. doi:10.1093/heapol/czy004.
   PubMed Web of Science ®Google Scholar
• Gilbert C, Fielder A, Gordillo L, et al. International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005 May;115(5)e518–25. doi:10.1542/peds.2004-1180.
   PubMed Web of Science ®Google Scholar
• Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for retinopathy of prematurity cooperative group. Arch Ophthalmol. 1990 Feb;108(2):195–204. doi:10.1001/archopht.1990.01070040047029.
   PubMed Web of Science ®Google Scholar
• Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001 Aug;119(8):1110–1118. doi:10.1001/archopht.119.8.1110.
   PubMedGoogle Scholar
• Laser therapy for retinopathy of prematurity. Laser ROP study group. Arch Ophthalmol. Feb, 1994;112(2):154–156.
   Google Scholar
• Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233–250. discussion 248-50.
   PubMedGoogle Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003 Dec;121(12):1684–1694. doi:10.1001/archopht.121.12.1684.
   PubMedGoogle Scholar
• McLoone E, O’Keefe M, McLoone S, Lanigan B. Long term functional and structural outcomes of laser therapy for retinopathy of prematurity. Brit-J-Ophthalmol. 2006;90(6):754–759. doi:10.1136/bjo.2005.068304.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011 Feb 17;364(7):603–615. doi:10.1056/NEJMoa1007374.
   PubMed Web of Science ®Google Scholar
• Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD009734. doi:10.1002/14651858.CD009734.pub3.
   PubMedGoogle Scholar
• Richter GM, Williams SL, Starren J, Flynn JT, Chiang MF. Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Surv Ophthalmol. 2009;54(6):671–685. doi:10.1016/j.survophthal.2009.02.020.
   PubMed Web of Science ®Google Scholar
• Chiang MF, Quinn GE, Fielder AR, et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. Oct 2021;128(10):e51–e68. doi:10.1016/j.ophtha.2021.05.031.
   PubMed Web of Science ®Google Scholar
• Braverman RS, Enzenauer RW. Socioeconomics of retinopathy of prematurity in-hospital care. Arch Ophthalmol. 2010;128(8):1055–1058. doi:10.1001/archophthalmol.2010.151.
   PubMedGoogle Scholar
• Hawn VS, Muhtadi R, Suman PD, Mian U. Expended effort and estimated compensation for ophthalmological retinopathy of prematurity services at a single institution. Invest Ophthalmol Vis Sci. 2021;62:2658.
   Web of Science ®Google Scholar
• McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epid. 2016;75:40–46. doi:10.1016/j.jclinepi.2016.01.021.
   PubMed Web of Science ®Google Scholar
• https://www.covidence.org. Accessed December 12, 2021.
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epid. 2021;134:103–112. doi:10.1016/j.jclinepi.2021.02.003.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Int J Tech Assess Health Care. 2013;29(2):117–122. doi:10.1017/S0266462313000160.
   PubMed Web of Science ®Google Scholar
• Fayanju OM, Haukoos JS, Tseng JF. CHEERS reporting guidelines for economic evaluations. JAMA Surg. 2021;156(7):677–678. doi:10.1001/jamasurg.2021.0540.
   PubMed Web of Science ®Google Scholar
• Castillo-Riquelme MC, Lord J, Moseley MJ, Fielder AR, Haines L. Cost-effectiveness of digital photographic screening for retinopathy of prematurity in the United Kingdom. Int J Tech Assess Health Care. 2004;20(2):201–213. doi:10.1017/S0266462304000984.
   PubMed Web of Science ®Google Scholar
• Isaac M, Isaranuwatchai W, Tehrani N. Cost analysis of remote telemedicine screening for retinopathy of prematurity. Cdn J Ophthalmol. 2018;53(2):162–167. doi:10.1016/j.jcjo.2017.08.018.
   Web of Science ®Google Scholar
• Jackson KM, Scott KE, Zivin JG, et al. Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management. Arch Ophthalmol. 2008;126(4):493–499. doi:10.1001/archopht.126.4.493.
   PubMedGoogle Scholar
• Dunbar JA, Hsu V, Christensen M, Black B, Williams P, Beauchamp G. Cost-utility analysis of screening and laser treatment of retinopathy of prematurity. J AAPOS. 2009;13(2):186–190. doi:10.1016/j.jaapos.2008.10.014.
   PubMed Web of Science ®Google Scholar
• Kamholz KL, Cole CH, Gray JE, Zupancic JA. Cost-effectiveness of early treatment for retinopathy of prematurity. Pediatrics. 2009;123(1):262–269. doi:10.1542/peds.2007-2725.
   PubMed Web of Science ®Google Scholar
• Lee SK, Normand C, McMillan D, Ohlsson A, Vincer M, Lyons C& Canadian Neonatal Network. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med. 2001;155(3):387–395. doi:10.1001/archpedi.155.3.387.
   PubMedGoogle Scholar
• Rothschild MI, Russ R, Brennan KA, et al. The economic model of retinopathy of prematurity (EcROP) screening and treatment: Mexico and the United States. Am J Ophthalmol. 2016;168:110–121. doi:10.1016/j.ajo.2016.04.014.
   PubMed Web of Science ®Google Scholar
• Yanovitch TL, Siatkowski RM, McCaffree M, Corff KE. Retinopathy of prematurity in infants with birth weight≥ 1250 grams—incidence, severity, and screening guideline cost-analysis. J AAPOS. 2006;10(2):128–134. doi:10.1016/j.jaapos.2005.08.005.
   PubMed Web of Science ®Google Scholar
• Zupancic JA, Ying GS, de Alba Campomanes A, Tomlinson LA, Binenbaum G. Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the postnatal growth and ROP (G-ROP) study. J Perinatology. 2020;40(7):1100–1108. doi:10.1038/s41372-020-0605-5.
   PubMed Web of Science ®Google Scholar
• Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276(16):1339–1341. doi:10.1001/jama.1996.03540160061034.
   PubMed Web of Science ®Google Scholar
• Gold M. Panel on cost-effectiveness in health and medicine. Med Care. 1996;34:DS197–DS199.
   PubMed Web of Science ®Google Scholar
• https://www.ofx.com/en-ca/forex-news/historical-exchange-rates/usd/gbp. Accessed December 11, 2021.
   Google Scholar
• https://www.ons.gov.uk/economy/inflationandpriceindices/timeseries/d7bz/mm23. Accessed December 11, 2021.
   Google Scholar
• McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26(9):733–744. doi:10.2165/00019053-200826090-00004.
   PubMed Web of Science ®Google Scholar
• Claxton K, Martin S, Soares M, et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess. Feb 2015;19(14):1–503. doi:10.3310/hta19140.
   PubMed Web of Science ®Google Scholar
• Wang S, Gum D, Merlin T. Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC-Does the presence of an explicit threshold affect the ICER Proposed? Value Health. 2018 Aug;21(8):938–943. doi:10.1016/j.jval.2018.01.017.
   PubMed Web of Science ®Google Scholar
• Jacobsen E, Boyers D, Avenell A. Challenges of systematic reviews of economic evaluations: a review of recent reviews and an obesity case study. Pharmacoeconomics. 2020;38(3):259–267. doi:10.1007/s40273-019-00878-2.
   PubMed Web of Science ®Google Scholar
• Kemper AR, Prosser LA, Wade KC, et al. e-ROP Study Cooperative Group. A comparison of strategies for retinopathy of prematurity detection. Pediatrics. 2016 Jan;137(1)e20152256. doi:10.1542/peds.2015-2256.
   PubMed Web of Science ®Google Scholar
• Redd TK, Campbell JP, Brown JM, et al. Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity [published online ahead of print, 2018 Nov 23]. Br J Ophthalmol. Nov 2018;23: bjophthalmol-2018-313156.doi:10.1136/bjophthalmol-2018-313156
   Google Scholar
• van Mastrigt GAPG, Hiligsmann M, Arts JJC, et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):689–704. doi:10.1080/14737167.2016.1246960.
   PubMed Web of Science ®Google Scholar